Turning Point Therapeutics, Inc.

TPTX · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$237-$157-$72-$25
Dep. & Amort.$4$2$2$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$59$64$13$1
Change in WC$15$7$1$0
Other Non-Cash$5$1-$1-$0
Operating Cash Flow-$154-$83-$58-$24
Investing Activities
PP&E Inv.-$2-$1-$2-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$439-$619-$432$0
Inv. Sales/Matur.$447$410$73$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$5-$210-$361-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$24$785$366$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$24$799$366$80
Financing Cash Flow$24$799$366$80
Forex Effect$0$0$0$0
Net Chg. in Cash-$124$506-$53$56
Supplemental Information
Beg. Cash$554$48$101$45
End Cash$430$554$48$101
Free Cash Flow-$156-$84-$60-$24